Boehringer ingelheim selects veeva development cloud worldwide to bring innovative therapies to patients faster

With veeva development cloud, boehringer ingelheim aims to establish a connected technology landscape for agile collaboration that can accelerate the development of novel medicines transformation focuses on reducing complexity and developing an innovative, digital culture to better understand and address unmet medical needs ingelheim, germany and pleasanton,calif., march 29, 2022 /prnewswire/ -- boehringer ingelheim and veeva systems (nyse: veev) today announced boehringer ingelheim's selection of veeva development cloud to drive end-to-end processes and seamless information sharing for greater speed in the delivery of innovative therapies.
VEEV Ratings Summary
VEEV Quant Ranking